LDR | |
00973nam a2200265 a 4500 |
001 |
|
002609431 |
003 |
|
MiAaHDL |
005 |
|
20210817000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
930406s1987 mdu f000 0 eng d |
035 |
⊔ |
⊔ |
‡a(MiU)990026094310106381
|
035 |
⊔ |
⊔ |
‡asdr-miu.990026094310106381
|
035 |
⊔ |
⊔ |
‡a(OCoLC)15725447
|
035 |
⊔ |
⊔ |
‡z(MiU)Aleph002609431
|
040 |
⊔ |
⊔ |
‡aGPO
‡cGPO
‡dm/c
‡dEYM
|
043 |
⊔ |
⊔ |
‡an-us---
|
074 |
⊔ |
⊔ |
‡a499-K-2
|
086 |
0 |
⊔ |
‡aHE 20.4208:An 8
|
245 |
0 |
0 |
‡aGuideline for the format and content of the summary for new drug and antibiotic applications.
|
260 |
⊔ |
⊔ |
‡aRockville, Md. :
‡bCenter for Drugs and Biologics, Food and Drug Administration, Dept. of Health and Human Services,
‡c1987.
|
300 |
⊔ |
⊔ |
‡a24 p. ;
‡c28 cm.
|
500 |
⊔ |
⊔ |
‡a"February 1987."
|
500 |
⊔ |
⊔ |
‡aShipping list no.: 87-243-P.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
2 |
‡aDrug Approval
‡zUnited States.
|
650 |
⊔ |
2 |
‡aInvestigational New Drug Application
‡xmethods
‡zUnited States.
|
650 |
⊔ |
0 |
‡aAntibiotics.
|
650 |
⊔ |
0 |
‡aDrugs
‡zUnited States.
|
710 |
2 |
⊔ |
‡aCenter for Drugs and Biologics (U.S.)
|
CID |
⊔ |
⊔ |
‡a002609431
|
DAT |
0 |
⊔ |
‡a19930406000000.0
‡b20210817000000.0
|
DAT |
1 |
⊔ |
‡a20210921140708.0
‡b2023-10-12T17:50:06Z
|
CAT |
⊔ |
⊔ |
‡aSDR-MIU
‡dALMA
‡lprepare.pl-004-008
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-miu.990026094310106381
‡aMiU
‡bSDR
‡cMIU
‡pmdp.39015029202226
‡sMIU
‡1990026094310106381
|
974 |
⊔ |
⊔ |
‡bMIU
‡cMIU
‡d20231012
‡sgoogle
‡umdp.39015029202226
‡y1987
‡rpd
‡qbib
‡tUS fed doc
|